It is now recommended that NOACs are chosen over warfarin, in patients with atrial fibrillation, except in patients with moderate to severe mitral valve stenosis or a mechanical heart valve.  • 

Matthew DeLaney, MD, FACEP, FAAEM • Neda Frayha, MD • Tarlan Hedayati, MD